Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
37.40
-0.08 (-0.21%)
Feb 4, 2026, 2:33 PM EST - Market open

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,1541,9621,8923,2682,4932,057
Market Cap Growth
-3.28%3.73%-42.12%31.09%21.23%-
Enterprise Value
1,6441,7371,7213,1552,4962,028
Last Close Price
37.4834.4132.3055.1042.6436.15
PE Ratio
11.7913.4914.6818.0172.07-
Forward PE
9.6511.8211.1423.0125.2735.10
PS Ratio
2.612.753.257.478.1612.87
PB Ratio
2.582.984.058.1113.3721.16
P/TBV Ratio
2.903.605.7413.5158.54-
P/FCF Ratio
7.238.988.6422.6525.37-
P/OCF Ratio
7.218.938.6222.6225.30-
PEG Ratio
0.360.470.73---
EV/Sales Ratio
1.992.432.967.218.1712.69
EV/EBITDA Ratio
6.598.087.9521.9823.4674.48
EV/EBIT Ratio
7.289.108.9626.2528.51119.37
EV/FCF Ratio
5.547.957.8621.8725.40-
Debt / Equity Ratio
0.200.280.420.481.052.00
Debt / EBITDA Ratio
0.680.840.901.341.827.14
Debt / FCF Ratio
0.570.830.901.351.99-
Asset Turnover
0.770.790.780.790.710.60
Inventory Turnover
26.7024.9725.1019.1313.4511.30
Quick Ratio
3.463.142.614.795.011.86
Current Ratio
3.763.312.755.075.291.95
Return on Equity (ROE)
25.93%25.84%29.63%61.58%24.39%-86.32%
Return on Assets (ROA)
13.20%13.17%16.16%13.57%12.71%3.98%
Return on Invested Capital (ROIC)
50.96%42.39%48.91%56.97%76.78%27.24%
Return on Capital Employed (ROCE)
22.90%23.20%29.60%20.20%23.10%5.80%
Earnings Yield
8.65%7.41%6.81%5.55%1.39%-1.80%
FCF Yield
13.83%11.14%11.58%4.42%3.94%-0.14%
Buyback Yield / Dilution
-1.02%4.15%1.19%-3.19%-129.72%-231.37%
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q